Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.

Markus F. Neurath, Ivan J. Fuss, Brian L. Kelsall, +3

The Journal of Experimental Medicine

Chronic Inflammatory DiseasesImmune ToleranceExperimental Granulomatous ColitisImmunologyGastroenterology +16

Monoclonal antibodies recognizing transforming growth factor-<i>beta</i>. Bioactivity neutralization and transforming growth factor <i>beta</i> 2 affinity purification.

James R. Dasch, Doran R. Pace, Wendy Waegell, +2

The Journal of Immunology

Immunocytochemical Localization and Serologic Detection of Transforming Growth Factor β1

H. Higley, K. Persichitte, Samuel Kai Wah Chu, +3

Arthritis & Rheumatism

Transforming growth factor‐β inhibits interleukin‐12‐induced production of interferon‐γ by natural killer cells: A role for transforming growth factor‐β in the regulation of T cell‐independent resistance to <i>Toxoplasma gondii</i>

Christopher A. Hunter, Luiz E. Bermudez, Hans Beernink, +2

European Journal of Immunology

Immune RegulationImmunologyImmunologic MechanismCd4 T Cell ResponsesImmune System +19

Transforming growth factor-βs are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation

Larry Ellingsworth, Debra Nakayama, Patricia R. Segarini, +3

Cellular Immunology

Interleukin-1-induced Thymocyte ProliferationMedicineImmunologyCell ProliferationT Cell Immunity +5

Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice.

J H Lowrance, Frank X. O’Sullivan, T E Caver, +2

The Journal of Experimental Medicine

Transforming growth factor- <i>beta</i> 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.

Clifford M. Snapper, Wendy Waegell, Hans Beernink, +1

The Journal of Immunology

A-770041, a Novel and Selective Small-Molecule Inhibitor of Lck, Prevents Heart Allograft Rejection

Robert F. Stachlewitz, Michelle Hart, Brian R. Bettencourt, +6

Journal of Pharmacology and Experimental Therapeutics

Dual Blockade of TNF and IL-17A Inhibits Inflammation and Structural Damage in a Rat Model of Spondyloarthritis

Ihsan Hammoura, Renée H. Fiechter, Shaughn H. Bryant, +8

International Journal of Molecular Sciences

A-420983: a potent, orally active inhibitor of lck with efficacy in a model of transplant rejection

David W. Borhani, David J. Calderwood, Michael Friedman, +7

Bioorganic & Medicinal Chemistry Letters

Transplant RejectionActive InhibitorTransplantationMedicineImmunosuppressive Therapy +8